The Attorneys General of Alaska, Arkansas, Arizona, California, Connecticut, District of Columbia, Georgia, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Michigan, Minnnesota, Missouri, Montana, Nebraska, New Mexico, North Dakota, Oregon, Puerto Rico, Rhode Island, South Carolina, Oklahoma, Tennessee, Utah, Vermont, and West Virginia (30 of them) wrote a very unhappy letter to director Karen Tandy, complaining about how the DEA is dealing with pain medication and concerned that the DEA is “infringing on the legitimate practice of medicine or exerting a chilling effect on the willingness of physicians to treat patients who are in pain.”
Read all about it, including the actual text of the letter, at The Agitator.
- DrugWarRant.com, the longest running single-issue blog devoted to drug policy
Join us on Pete's couch.
Send comments, tips,
and suggestions to: New opioid discovery DFNZ has effective pain relief but does not cause respiratory depression or tolerance: 1-Apr-2026 -- Researchers at…
Sara Carter is the new Drug Czarina (Director of ONDCP). She is a former journalist and Fox News contributor who…
Genetic risk tied to neural impulse control in the brain's wiring affects addiction outcomes for drug users: 20-Mar-2026 -- Most…
Prevalence of drink spiking in the United Kingdom is surveyed: 19-Mar-2026 -- Since 2021, forensic science academics at ARU have…
Psilocybin is found to be an effective treatment for obsessive compulsive disorder (OCD): Current treatments for obsessive–compulsive disorder (OCD), including…